Freedman RS - Search Results

1

Randomized comparison of viral oncolysate plus radiation and radiation alone in uterine cervix carcinoma.

Freedman RS, Bowen JM, Atkinson EN, Wallace S, Lotzová E, Silva E, Edwards CL, Delclos L, Scott W, Patenia B, et al. Freedman RS, et al. Am J Clin Oncol. 1989 Jun;12(3):244-50. doi: 10.1097/00000421-198906000-00013. Am J Clin Oncol. 1989. PMID: 2499178 Clinical Trial.

2

Lymphokine activity in malignant effusions after intracavitary viral oncolysate.

Freedman RS, Kouttab NM, Bowen JM, Edwards CL, Katz RL. Freedman RS, et al. Lymphokine Res. 1989 Summer;8(2):115-22. Lymphokine Res. 1989. PMID: 2786595

3

Viral oncolysates in patients with advanced ovarian cancer.

Freedman RS, Edwards CL, Bowen JM, Lotzova E, Katz R, Lewis E, Atkinson N, Carsetti R. Freedman RS, et al. Gynecol Oncol. 1988 Mar;29(3):337-47. doi: 10.1016/0090-8258(88)90233-8. Gynecol Oncol. 1988. PMID: 3345954

4

Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix.

Verschraegen CF, Levy T, Kudelka AP, Llerena E, Ende K, Freedman RS, Edwards CL, Hord M, Steger M, Kaplan AL, Kieback D, Fishman A, Kavanagh JJ. Verschraegen CF, et al. Among authors: freedman rs. J Clin Oncol. 1997 Feb;15(2):625-31. doi: 10.1200/JCO.1997.15.2.625. J Clin Oncol. 1997. PMID: 9053486 Clinical Trial.

5

Phase I evaluation of thio-TEPA in combination with cisplatin for advanced gynecologic malignancies.

Sandles LG, Freedman RS, Raber MN, Kavanagh J, Edwards CL, Scott WR, Wharton JT. Sandles LG, et al. Among authors: freedman rs. Gynecol Oncol. 1990 Nov;39(2):139-45. doi: 10.1016/0090-8258(90)90421-g. Gynecol Oncol. 1990. PMID: 2121628

6

T-cell functions in ovarian cancer patients treated with viral oncolysates: I. Increased helper activity to immunoglobulins production.

Ioannides CG, Platsoucas CD, Patenia R, Kim YP, Bowen JM, Morris M, Edwards C, Wharton JT, Freedman RS. Ioannides CG, et al. Among authors: freedman rs. Anticancer Res. 1990 May-Jun;10(3):645-53. Anticancer Res. 1990. PMID: 2142392

7

Comparison of recombinant-interleukin-2-activated peripheral blood and tumor-infiltrating lymphocytes of patients with epithelial ovarian carcinoma: cytotoxicity, growth kinetics and phenotype.

Lotzová E, Savary CA, Freedman RS, Edwards CL, Morris M. Lotzová E, et al. Among authors: freedman rs. Cancer Immunol Immunother. 1990;31(3):169-75. doi: 10.1007/BF01744732. Cancer Immunol Immunother. 1990. PMID: 2337905 Free PMC article.

8

Treatment of advanced endometrial adenocarcinoma with cyclic sequential ethinyl estradiol and medroxyprogesterone acetate.

Tatman JL, Freedman RS, Scott W, Atkinson EN. Tatman JL, et al. Among authors: freedman rs. Eur J Cancer Clin Oncol. 1989 Nov;25(11):1619-21. doi: 10.1016/0277-5379(89)90307-6. Eur J Cancer Clin Oncol. 1989. PMID: 2531671

9

Effect of virus-modified tumor cell extracts, autologous mononuclear cell infusions and interleukin-2 on oncolytic activity of effector cells of patients with advanced ovarian cancer.

Furukawa K, Lotzová E, Freedman RS, Bowen JB, Edwards CL, Wharton JT. Furukawa K, et al. Among authors: freedman rs. Cancer Immunol Immunother. 1989;30(2):126-32. doi: 10.1007/BF01665964. Cancer Immunol Immunother. 1989. PMID: 2598179 Free PMC article.

10

Viral oncolysates in cancer treatment: immunological mechanisms of action (review).

Ioannides CG, Platsoucas CD, O'Brian CA, Patenia R, Bowen JM, Wharton JT, Freedman RS. Ioannides CG, et al. Among authors: freedman rs. Anticancer Res. 1989 May-Jun;9(3):535-44. Anticancer Res. 1989. PMID: 2669619 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters